Active substance: Salbutamola Sulfate 120.5 μg in one dose (equivalent to 100 μg salbutamola).
Auxiliary substances: propellant GR106642X (1,1,1,2-tetrafluoroethane, also known as HFA 134a or Norflouran). Does not contain chlorofluorocarbon phones.
Metal inhaler with an indulged bottom, equipped with a dosing valve containing a suspension of white or almost white. There should be no damage on the inner surface of the inhaler.
Means for the treatment of obstructive diseases of the respiratory tract. Adrenergic means for inhalation. Selective beta-2-adrenoreceptor agonists.
The codeATH:R03ac02.
Pharmacological properties
Pharmacodynamics
Salbutamol is a selective agonist of beta-2-adrenoreceptor.
After the inhalation use, Salbutamol has a stimulating effect on the Beta-2-adrenoreceptors of the smooth muscles of the bronchi, thus providing quick bright browsection, which manifests itself in a few minutes and is preserved for 4-6 hours.
Pharmacokinetics
Salbutamol.
After the inhalation administration of the drug, its concentration in the blood plasma when taking ordinary doses is minor (10-50 times less than when administering the drug orally or by injection).
The relationship between the level of concentration in the blood and the effectiveness is absent. After pulmonary resorption, the drug is excreted mainly by the kidneys, partly unchanged (less than 2%), partly - in the form of inactive metabolites (phenolic sulfates).
1,1,1,2 - tetrafluoroethan: Obesting gas
After the inhalation administration of the drug, the adsorption of 1,1,1,2-tetrafluoroethane is insignificant and fast, the maximum concentration is achieved less than in 6 minutes.
In animals (mice and rats) there was a minor liver metabolism of the drug with the formation of trifluoroacetic acid and trifluoroacetic aldehyde. Nevertheless, according to the results of kinetic studies conducted among patients receiving 1,1,1,2-tetrafluoroethane in the presence of pathologies, cases of formation of trifluoroacetic acid were not detected.
Symptomatic treatment of attacks bronchial asthma.
Symptomatic treatment of exacerbations of bronchial asthma or chronic obstructive bronchitis.
Preventing asthma attacks caused by exercise.
Test for the reversibility of bronchial obstruction during the functional studies of the respiratory tract.
Allergic reaction to one of the components of the drug.
The intolerance to this medicinal product (the unexpected appearance of cough or the development of bronchospasm immediately after receiving the drug). In this case, it is necessary to discontinue treatment and assign other therapy or other methods of application.
Application during pregnancy and lactation
Pregnancy
Salbutamol.
IN clinical practice There is a sufficient amount of documented examples of the use of the drug during pregnancy, which allows you to conclude about the safe use of salbutamola during pregnancy.
Consequently, the use of salbutamol during pregnancy by inhalation administration is permissible.
When taking the drug during pregnancy:
A fetal heartbeat may be observed against the mother's tachycardia. In exceptional cases, the stupid heartbeat after birth is noted.
Similarly, in exceptional cases, a postnatal change in the level of glycemia is noted.
In the case of drug intake to childbirth, the vasodilator peripheral effect of beta-2-mimetics should be taken into account.
1,1,1,2 - tetrafluoroethan: Obesting gas
Reproductive function studies conducted on animals did not reveal the harmful effects caused by a reception of 1,1,1,2-tetrafluoroethane, which is contained in this drug.
Nevertheless, the consequences of the reception of 1,1,2-tetrafluoroethane in pregnant women are not installed.
Lactation
Beta-2-mimetics penetrate into breast milk.
The fact of penetration of the displacing gas and its metabolites into breast milk during the receipt of the drug is not installed.
Fertility
Information about the influence of Salbutamola on fertility in humans is missing. In preclinical studies of undesirable influence on fertility, animals were not identified.
Dosage
Regardless of age:
Treatment of attacks and aggravations of bronchial asthma: when the first symptoms appear to make 1-2 inhalations.
Prevention of asthma attacks caused by exercise: 1-2 inhalations 15-30 minutes before the start of physical activity.
In general, the dose of 1-2 inhalation is sufficient to treat breathing difficulties.
In the case of stability of symptoms, the dose can be repeated in a few minutes.
The duration of the bridal action of salbutamol during inhalation administration ranges from 4 to 6 hours.
When repeated occurrence Symptoms Reception of the drug can be repeated.
Usually daily dose The drug should not exceed 8 inhalations within 24 hours. If this dose is exceeded, the patient should be informed about the need for medical consultation in order to revise the indications for use (see the section "Precautions").
In the event of a severe acute attack of asthma or severe exacerbation of chronic obstructive bronchopneumopathy, the dose of the drug ranges from 2 to 6 inhalations, which should be repeated every 5-10 minutes before the arrival of emergency professionals medical care. In such situations, the use of an inhalation chamber is recommended, since it contributes to the acceleration of the pulmonary diffusion of salbutamola adopted by inhalation. However, repeatedly pressing the dosage inhaler and the release of doses into the inhalation chamber can shorten the total inhaled dose, and the patient must inhale the drug directly (or, if necessary, after each series of two consecutive clicks) from the inhaler after each pressing on the inhaler. In the future, the reception of the drug should be repeated by sequential cycles. A severe acute attack of bronchial asthma requires hospitalization. In this case, treatment is to carry out oxygen therapy and systemic therapy with corticosteroids.
Mode of application
Inhalation administration using a device in the form of a hermetic spray equipped with mouthpiece.
In order to correctly use the device, the doctor is recommended to make sure that the patient uses the inhaler correctly.
In the case of the patient, there is no synchronization of inhalation and pressing the inhaler, the use of an inhalation chamber is shown. Also in such patients it is possible to use other more adapted species dosage forms Salbutamola.
In children and infants who need to treat a suspension for inhalations salbutamol in the form of an aerosol, it is advisable to use an inhalation chamber equipped with a spacer.
The inhaler is not equipped with a dose counter.
Unwanted reactions are listed depending on the anatomy-physiological classification and frequency of occurrence, which is defined as follows: Very often (≥ 1/10), often (≥ 1/100 and
Organ class | Side effects | Frequency |
From the immune system | Hypersensitivity reactions, including: angioedema edema, urticule, strong itch, bronchospasm, hypotension, collapse. | Rarely |
From the metabolism | Hypokalemia. * | Rarely |
From the nervous system | Headache, tremor. | Often |
Mental disorders | Conduct disorders: irritability, excitement. | Rarely |
From heart | Tachycardia | Often |
Heart palpitations | Infrequently | |
Heart arrhythmias (including atrial fibrillation, supraventricular tachycardia and extrasystole). | Rarely | |
Myocardial ischemia (see section "Precautions"). | Frequency unknown ** | |
From the vessels | Peripheral vasodulation. | Rarely |
From the respiratory system, chest and mediastinal organs | Paradoxical bronchospasm *** | Rarely |
From the gastrointestinal tract | Irritation of the mucous membrane of the oral cavity and pharynx. | Infrequently |
From the bone-muscular system | Muscular cramps | Infrequently |
* Beta-2-mimetics in elevated doses can cause reversible hyperglycemia and hypokalemia during the cessation of treatment.
** The frequency of the myocardium ischemia is not possible, since it was reported in spontaneous reports obtained during post-paying surveillance.
*** As with the use of other drugs for inhalation therapy, there is a possibility of cough and, in rare cases, paradoxical bronchospasm immediately after inhalation. It is recommended to stop taking this medicinal product and use another equivalent bronchottizer of quick action to facilitate bronchospasm. In the future, it is recommended to reconsider treatment to assign alternative therapy if necessary.
Extremely rare cases of lactatacidosis in patients taking salbutamol intravenously either by inhalation administration using a nebulizer in the treatment of severe exacerbation of bronchial asthma were noted.
Digestion (nausea, vomiting) can also be noted.
Informing about possible side effects
The provision of information on suspected adverse reactions identified after registration is of great importance, as it makes it possible to conduct continuous monitoring of the benefit balance and risk of drugs. Report any suspected adverse reactions of health care specialists can through a national system of informing.
The symptoms and symptoms of the overdose of salbutamol are transient phenomena expressed in strengthening the pharmacodynamic effect of beta-2-agonists (see Sections "Precautions" and "Sidey").
The consequence of the overdose of Salbutamola may be hypocalemia. Therefore, in the event of an overdose, control of the concentration of potassium in serum is necessary.
Cases of nausea, vomiting and hyperglycemia were noted mainly in children and in cases where an overdose was due to oral administration of salbutamola.
Cases of lactatacidosis were noted when receiving elevated doses of beta-2-agonists of quick action. Consequently, under overdose, it is necessary to control the concentration of lactate in the blood of the blood, as well as the risk of lactatacidosis, in particular, in the case of stability or the deterioration of Tahipne, despite the disappearance of such symptoms of bronchospasm as a whistling breath, which may be associated with the development of metabolic acidosis.
Required actions: observation and symptomatic treatment.
Interaction with other drugs
+ Non-selective beta blockers
+ Halogen preparations for anesthesia (galotan)
When conducting obstetric surgical operations, an increase in the inertia of the uterus with the risk of bleeding was noted; In addition, there is a risk of developing serious ventricular arrhythmias when improving cardiac reactivity.
Combinations requiring compliance with precautions when used
+ Antidiabetic drugs
The reception of beta-2 mimetics is combined with an increase in glycemia, which can be interpreted as a decrease in the effect of antidiabetic therapy, therefore, it may be necessary to change anti-diabetic therapy (see section "Precautions"). Advanced control of blood and urine condition is recommended.
special instructions
Inform the patient about the need to immediately appeal for medical assistance in the event that the previously observed facilitation of the state occurs in the development of the attack of bronchial asthma.
Increasing the need for the use of broutine, in particular beta-2-agonists, may be a sign of the exacerbation of bronchial asthma or obstructive bronchopneumopathy. If within a few days the needs of the patient in the consumption of beta-2-mimetic bronchodulators for a long and short action By inhalation administration, it has increased significantly, it is necessary (especially if the peak values \u200b\u200bof the flow meter are reduced and / or become irregular) breathing decompensation, and asthmatics are the possibility of developing asthmatic status. Consequently, the doctor must inform the patient about the need to immediately appeal in a similar case for medical care without intentional exceeding the maximum prescribed doses. In such a situation, it is necessary to revise indications for use.
A sudden and progressive aggravation of the flow of bronchial asthma may be dangerous for life. In such a situation, it is necessary to provide therapy with corticosteroids or an increase in the dosages of existing therapy with corticosteroids. In addition, in adult patients suffering from asthma, inhalation therapy with corticosteroids should be carried out in the case when the use of mimetic beta-2-agonists is more often 1 time per week. In this case, it is necessary to inform the patient that the improvement of its clinical condition should not be a consequence of changes in therapy, in particular, the cessation of inhalation corticosteroids without a medical detention.
As with the use of other drugs for inhalation therapy, immediately after the use of the drug can develop paradoxical bronchospasm, which is manifested in a more pronounced breathing and strengthening wheezing. Bronchospasm requires the treatment of an alternative form of release of the drug or another bronchoditator for inhalation therapy (if available). The use of the drug Salbutamol inhalation should be immediately terminated and, if necessary, assign another high-speed broutine to continue treatment.
Drugs with sympathomimetic effects, to which salbutamol relates, can cause violations of the cardiovascular system. According to the data obtained during the previous period of the use of the drug, as well as in the literature, cases of the development of myocardial ischemia associated with the use of Salbutamola were noted. Patients with severe cardiopathiopathy of the underlying departments (for example, IBS, arrhythmia or severe heart failure) should be informed about the need to appeal to the attending physician in case of pain in chest Or other symptoms indicating the exacerbation of heart disease. Attention should be paid to the assessment of such symptoms such as shortness of breath and pain in the chest, which can be a consequence of both heart disease and diseases of the respiratory system.
Precautions when using
In the case of bronchial infection or abundant bronchio breed, it is necessary to carry out appropriate treatment, which contributes to the optimal diffusion of the drug in respiratory tract.
Salbutamol should be appointed with caution to patients receiving significant doses of other sympathomimetic drugs.
Receiving salbutamola in conventional doses by inhaled administration using the device in the form of a hermetic can usually cause adverse Reactions In patients suffering from hyperthyroidism, disorders of coronary circulation, obstructive cardiomyopathy, ventricular arrhythmia, arterial hypertension, diabetesIn contrast to salbutamola, the reception of which is carried out with the help of a nebulizer orally or by injection, which should be appointed with caution to such patients.
Therapy of beta-2-mimetics in elevated doses (especially when administered by parenterally or with a nebulizer) can lead to potentially severe hypokalemia, which can cause violations heart Rhythm. In such cases, it is recommended to control the level of potassium in serum, in particular, while using xanthine derivatives, GKS, diuretics, due to hypoxia, as well as in patients with high risk of developing arrhythmia type "Pirouette" (the elongated Qt interval or therapy, capable of lengthening the interval Qt).
Like other beta-2-agonists of adrenoreceptors, Salbutamol can cause an increase in blood glucose. In patients suffering from diabetes, cases of ketoacidosis were noted. The concomitant use of corticosteroids can strengthen this effect.
Extremely rare cases of lactatacidosis associated with the use of increased doses of beta-2-agonists of short-acting, intravenously either by inhalation using a nebulizer, were noted mainly in patients undergoing therapy to relieve Bronchial Asthma exacerbation (see Side Action "). The increase in the content of lactic acid can cause difficulty breathing or compensating hyperventilation, which may be incorrectly interpreted as a sign of unsuccessful treatment of asthma due to an inappropriate increase in the dosage of beta-agonists of short-acting. Consequently, the risk of lactatacidosis should be an object of close observation, especially in severe cases.
Athletes:
Athletes should take into account that this medicinal product contains active substancewhich can show positive results when conducting anti-doping control tests.
Impact on the ability to drive a car and / or other mechanisms
There is no data.
Form release
200 doses to an aluminum inhaler equipped with a plastic dosing device with a protective cap. The inhaler and the dosing device in the assembled form along with the application instructions are placed in a cardboard pack.
FROMrocksucidity
2 years. Do not apply after the expiration date indicated on the package.
At a temperature not higher than 30 ° C, do not freeze, prevent the effects of sun rays. Keep out of the reach of children.
Like most other inhalers in aerosol packages, salbutamol can be less effective at low temperatures. When cooling the canopy, it is recommended to get it from a plastic case and warm your hands for a few minutes. Caller cannot be disassembled, piercing and throwing into the fire, even if it is empty.
Conditions of vacation from pharmacies
On prescription.
Manufacturer
Legal address of the manufacturer:
Glaxo WELLOME PRODUCTION, FRANCE
23 RUE LAVOISIER - ZONE INDUSTRIELLE NO 2, EVREUX, FRANCE /
Glaxo Lelkom Production, France
Industrial Zone 2, Ryu Lavoisier 23, Evro, France.
For more information, contact the address:
Representation LLC "GlaxosmithKline Export Limited" (United Kingdom) in the Republic of Belarus
Minsk, ul. Voronoyansky, 7a, office 400
Tel.: +375 17 213 20 16; Fax + 375 17 213 18 66
Instructions for the use of inhaler
Check inhaler
Before the first use of the inhaler or in the event that the inhaler did not use 5 days and longer, remove the cap from the mouthpiece, slightly squeezing the cap from the sides, shake the inhaler well and click on the aerosol valve to release two inhalation doses into the air to make sure the inhale fee .
Using inhaler
Remove the cap from the mouthpiece, slightly squeezing the cap from the sides.
Inspect the mouthpiece from the inside and outside to make sure it is clean and does not contain extraneous particles.
Shake the inhaler well for uniform mixing the contents and to remove foreign particles.
Keep the inhaler between the index and thumb in vertical position bottom up thumb Must be located on the basis of the mouthpiece.
Make a slow deep exhalation, graze mouthpiece with lips, without squeezing his teeth.
Making a deep breath through the mouth, simultaneously press the upper part of the inhaler to release a single inhalation dose of salbutamola.
Hold the breath for a few seconds, remove the mouthpiece from the mouth, then slowly exhale.
To obtain a second dose, keeping the inhaler in a vertical position, wait about 30 s and then repeat step 3-7.
Tightly close the mouthpiece with a protective cap.
Attention! Performing stage 5, 6 and 7, you can not hurry. It should be inhaled as slowly as possible, immediately before pressing the inhaler valve. In the first few times it is recommended to practice in front of the mirror. If you see "fog", leaving the top of the inhaler or from the corners of the mouth, then you should start all over again from stage 3.
If the doctor gave you other instructions for using the inhaler, then keep them strictly. Contact your doctor if you have difficulty using the inhaler.
Cleaning inhaler
The inhaler must be cleaned at least once a week.
Remove the metal sprinkler from the plastic case and remove the mouthpiece cover.
Thoroughly rinse the plastic housing and the mouthpiece cover under the jet of warm water.
Dry the plastic housing and the mouthpiece cover is completely both outside and inside. Do not overheat.
Place the metal spray cylinder in the plastic case and wear the mouthpiece cover.
Do not immerse the metal balloon in the water.
The rights to possess trademarks belong to the group of companies GSK.
© 2018 GSK Group of Companies or their right holder.
Salbutamol Instructions for the use of which gives detailed instructions to use the drug, is a means appointed to relieve spasm in bronchi in the event of a choking. The peculiarity of the drug is that it is allowed to apply salbutamol during pregnancy and during lactation. Treatment of bronchial asthma - the process is long and even permanent. This is due to the fact that bronchial asthma is rated by diseases incurable, caused by many negative factors.
Will tell about how to use Salbutamol, instructions for use this drug. It describes all its advantages and features of the medicine. You should know by purchasing salbutamol that the form of release of this drug provides for an application in the form of an aerosol. The substance that has an active action is salbutamol in the dosage of 0.0725 mg per 100 mg of the drug. Salbutamol is one of the drugs, of which a group of synthetic tools created to combat asthmatic attacks, provide emergency medical care and preventing the development of suffocation.
As an additional component, oleate was introduced as an additional component, the dosage of which is 0.1449 mg for every 100 mg of the preparation. When creating salbutamola aerosol, intended for inhalations in the treatment of asthma, fluorrichloromethane and diefluorodichloromethane are used.
His action is directed to:In the instructions written in Salbutamol, it is said that this drug is used to provide emergency medical care in complicing the attack of bronchial asthma.
There are other forms of release. medicinal preparationwhich are in high demand in the elimination of asthmatic suffocation and prevent the development of a re-attack of asthma.
Doctors recommend:In the course of the therapeutic measures under the hospital, the use of salbutamol medication produced in the form of a solution for intravenous invasions is possible. It is a salbutamol with a drug that is characterized by a mercolytic, and the pharmacology and composition of this drug speaks about the possibility of using the drug as a medicine with an anti-inflammatory effect.
With bronchial asthma, manufacturers recommend applying an inhalation aerosol, since this bright agent is characterized by a tocolic effect and contributes to the expansion of the bronchi, increasing the lumen of the respiratory tract and facilitating the patient's breathing. The composition of the drug, its group affiliation and pharmacodynamics confirm that Salbutamol quickly and effectively stop the attack of asthma, helps to deal with inflammatory process, developing in respiratory tract due to abundant allocation and accumulation of mucus.
The effect of the drug is directed to:
Directly pharmachologic effect The drug begins after 3-5 minutes after entering the active component (active ingredient) into the patient's body.
The mechanism of action is associated with the peculiarities of the influence on the beta2-adrenoreceptors of the smooth muscles of the bronchi, as a result of which the muscles of the respiratory organs relax and the lumen of the trunk and branches of the bronchial tree is expanding. Part of the dose of medicine adopted by patients during inhalation when an asthma attack occurs directly in the respiratory tract and lung patient, providing local action Depending on where the focus of inflammation is located and the place of narrowing the lumen of the bronchi.
In addition, under the influence of salbutamola, the allocation and removal of mucus from the respiratory organs is activated, the work of the fiscal epithelium is improved, which prevents the development of asthma attack due to contact with the allergen.
The use of salbutamola solution for inhalation is distinguished by special efficiency during the fight against asthmatic suffocation. The inhaler is a cylinder made of aluminum, equipped with a special valve and dispenser, when pressed for which medicinal composition is sprayed. Manufacturers produce designed and created for salbutul analogs in the form of capsules with powder powder for inhalation, tablets, syrup or spray.
Solving than replacing Salbutamol, it is necessary to consult with the attending physician. Otherwise the proper result may not be, but side effects Instantly let yourself know.
The use of salbutamola is possible strictly to appoint a doctor. The substances included in its composition are not always useful to patients in need of an urgent stopping attack of asthma. Annotation says that often hormonal drug With incorrect reception, it is addictive.
Indications for use include:Listing the testimony for the use of Salbutamola, you can call the suddenly starting suffocation against the background of premature birth.
Many doctors argue that the use of Salbutamola in the first trimester of pregnancy entails a change in a certain level of hormone content, which becomes the cause of violation of the physiological course of pregnancy.
There are certain rules for the reception of the drug in the form of tablets, syrup or spray, use for inhalation nebulizer or intravenous administration.
Existing contraindications to the use of Salbutola say that with extreme caution, you should use this medicine to patients with hyperglycemia, but the absolute indication for receiving the drug is:
Appearance side Effects After applying the drug, it may be the consequence of the overdose of salbutamola or incorrect drug intake. To use such a device as an inhaler is necessary in strict accordance with the attached instruction. There is no reason for the appearance of side effects only an aerosol for inhalations. In other cases, the excess of the dosage indicated in the annotation leads to a violation of the heart rhythm and other difficult consequences.
The most dangerous side effects:
Pretty rarely manifest allergic reactionsThe development of which is capable of provoking the approximate Salbutamola.
Their manifestation is associated with the gloomy, rash on the skin, itching, insignificant burning. Any manifestation of a negative response to the drug is an indication to the termination of therapy with its help.
Before proceeding with the treatment of salbutomol, it is necessary to make sure that there are no contraindications and compatibility of this medication with other substances used. The interaction of salbutamola with diuretic drugs leads to the development of hypokalemia, and with simultaneous admission with the means of breathing, tachycardia may appear and the heart rate disruption.
In such cases, the reception of Salbutamola should be immediately discontinued, but only a qualified doctor is capable of choosing a substitute. Completely incompatible with Salbutotol, bad habits, such as smoking and alcohol. Contraindication is also 1 trimester of pregnancy, when there is no placental barrier and the drug components can cause harm to the emerging fetus.
The method of using salbutamola 100 μg is an aerosol appointed by children before the upcoming physical activity.
Often parents use the inhaler as preventive toolBut this can be done only at the instructions of the attending physician:
The choice of the appointed dosage depends on the age of the patient. Children under 12 recommended a reception of 100 μg per day. Teenagers and senior patients are 200 μg as a single dose. The drug has an action for a short time, and with its help you can quickly stop the attack of an asthmatic choking.
For high levels The risk of contact with the allergen requires the prophylactic dose of salbutamola, but in cases where the medicine is used as a prophylactic agent with the possibility of developing the attack of choking, the patient takes 2 doses (2 inhalations) simultaneously. This means that he needs to shake the inhaler, turn it down by the dispenser and introduce the mouthpiece into the oral cavity.
The procedure cannot be performed with filled with light, since the drug makeup should penetrate the most distant corners of the lungs. To do this, you will need to make a complete exhale, then slowly breathing air, click on the cap of the dispenser and delay the breathing for 30 seconds. Can be repeated inhalation with a strong attack or in the absence of therapeutic effect. It is necessary to wait at least 5 minutes. It is important to remember that the premature repetition of inhalation can cause the manifestation of side effects.
Time limit: 0
0 of 11 tasks ended
This test will help you determine if you have asthma.
You have already passed the test earlier. You can't run it again.
The test is loaded ...
You must login or register in order to start the test.
You must finish the following tests to start this:
Time is over
Now with your health is all right. Do not forget to follow the same well and take care of your body, and no diseases will not be terrible.
The symptoms that are bothering you indicate that in your case the development of asthma can begin, or it is already the initial stage. We recommend that you contact a specialist and pass a medical examination to avoid complications and cure a disease at the point. We also recommend reading the article about that.
In your case, bright symptoms of asthma are observed! You need to urgently get to a qualified specialist, only the doctor will be able to put an accurate diagnosis and prescribe treatment. We also recommend reading the article about that.
Task 1 of 11
Does you worry a strong and painful cough?
Task 2 of 11
Do you have a cough when you are in the cold air?
Task 3 of 11
Does the sword worries you at which it becomes difficult to exhale and is breathing?
Task 4 of 11
Have you noticed whistling wheezing during breathing?
Task 5 of 11
Do you have a stitching attacks?
MNN: Salbutamol.
Manufacturer: Laboratories Aldo-Yunion S.A.
Anatomy-therapeutic-chemical classification: Salbutamol
Registration number in Kazakhstan: No. RK-LS-5№019225
Registration period: 15.02.2018 - 15.02.2023
KNF (LS Included in the Kazakhstan National Medicinal Form)
Alo (included in the list of free outpatient medicinal support)
UG (included in the LS List in the GBCM, to be purchased from the Unified Distributor)
Salbutamol.
Salbutamol.
Inhalation aerosol, metered, 100 μg / dose, 200 doses
One dose contains
active substance -salbutamola sulfate 120.5 μg (equivalent to salbutamol 100 μg),
excipients: Tetrafluoroethane, oleinic acid, ethanol.
Uniform white suspension
Preparations for the treatment of obstructive diseases of the respiratory tract. Beta 2-adrenostimulants selective.
Code ATHR03AC02.
Pharmacokinetics
After inhalation, about 10-20% of the active substance reaches small bronchi, the rest of the amount settles in the upper respiratory departments. When taking inside, including with partial swallowing during inhalation, salbutamol is well absorbed from the gastrointestinal tract. Pressure metabolism of salbutamola occurs mainly in gastrointestinal By conjugation with ester of inactive sulfate. Due to the gradual absorption of bronchi, systemic levels of salbutamola are low after the inhalation of the recommended dose. The maximum plasma concentrations are achieved in 2-4 hours. Communication with plasma proteins - 10%. Penetrates the placenta. Salbutamola's system clearance is 30 liters / hour. Salbutamol is removed with urine unchanged and in the form of a phenalsulfate metabolite. The half-life ranges from 3 to 7 hours. Approximately 72% of the dose is derived from the urine for 24 hours and consists of 28% of the unchanged preparation and 44% of metabolite. Salbutamol does not pass through the hematostephalic barrier.
Pharmacodynamics
Salbutamol is a selective β2-adrenoreceptor agonist. In therapeutic doses, it stimulates the β2-adrenoreceptors of the smooth muscles of the bronchi, having a minor effect or at all without affecting β1-adrenoreceptors. It has an armored effect, warning or binding bronchial spasms, increases the life capacity of the lungs, reduces resistance in the respiratory tract. Thus, salbutamol has a rapid broncholy action, which lasts for 4-6 hours.
In recommended therapeutic doses does not have negative influence On the cardiovascular system, it does not cause an increase in blood pressure. To a lesser extent compared to drugs This group has a positive chrono and inotropic effect. Causes the expansion of the coronary arteries.
It has a number of metabolic effects: reduces plasma potassium concentration, affects glycogenolysis and insulin selection, hyperglycemic (especially in patients with bronchial asthma) and a lipolytic effect increases the risk of acidosis.
Symptomatic treatment of bronchospasm, bronchial asthma and / or reversible respiratory tract
Prevention of bronchospasm caused by exercise or in situations of the inevitable effects of allergen
It applies only inhalation in accordance with the recommendations of the doctor. Salbutamol can be used with the spacer patients who are difficult to synchronize the dose of aerosol with a breath.
Adults (including elderly patients)
To stop the acute attack of bronchospasm and episodes of an intermittent asthma, 100 μg is used (1 inhalation). The dose can be increased to two inhalations, if necessary.
For the prevention of the attack of bronchospasm caused by physical activity or affected by the effects of allergen, 1 or 2 inhalations 10-15 minutes before the impact of the provoking factor.
Children: Recommended dose for relief acute symptoms Asthma, including bronchospasm, or to the effects of allergen or exercise of 100 μg (1 ingulation). For the prevention of the attack - up to 100-200mkg (1-2 inhalation) 4 times a day. If the answer is inadequate, you can use more than one inhalation.
The bronchology effect after each application lasts at least 4 hours, except for patients who have asthma progresses. If you need to increase the dose or the use of systemic glucocorticosteroids, you should consult with your doctor.
The need to increase the dose indicates the progression of the disease.
Instructions for using inhaler
The effect of the drug can be loosened if the cold inhaler. When cooling the can, it is recommended to get it out of a plastic case and warm your hands for a few minutes. Caller cannot be disassembled, piercing and throwing into the fire, even if it is empty.
Checking the health of the inhaler
Carefully remove the lid from the mouthpiece, vigorously shake the inhaler and spray two doses of the drug into the air. If the inhaler has not been used for several days, shake well and spray one dose of the drug in the air to make sure.
The use of inhaler
A. Remove the protective cap from the inhaler mouthpiece. Check clean and dry Municipality.
B. Shake inhaler vigorously.
C. Place the inhaler vertically between big and index fingers, placing a thumb on the base below the mouthpiece.
D. Make a deep exhale. Then place the mouthpiece between the teeth (without biting it) and tightly clap her lips.
E. Make a deep breath through the mouth. Continuing to take a deep breath, press the upper part of the inhaler. Pressing the inhaler should be at the beginning of a calm, deep breath.
F. Hold your breath, remove the inhaler from the mouth and remove the index finger from the top of the inhaler. Continue to restore your breath as possible.
H. If you need to continue inhalation, you should wait approximately half a minute, keeping the inhaler vertically, and then repeat the steps from B by F. After inhalation, put on the mouthpiece dust caps.
The drug is applied to the appointment of a doctor and it is necessary to inform it about any difficulties associated with the reception of the drug.
Side effects are listed below, based on the classification by frequency. Frequency classification: Very often (≥1 / 10), often (≥1 / 100, but<1/10), нечасто (≥1/1000, но <1/100), редко (≥1/10 000, но <1/1000) и очень редко (<1/10000).
Often
Tachycardia, Tremelor, Headache, Dizziness
Infrequently
Heartbeat, voltage feeling
Nausea, vomiting
Irritation of the mucous membrane of the oral cavity and pharynx, changing taste sensations
Muscular spasmod
Seldom
Hypokalemia, which can be potential for corticosteroids, diuretics and xanthines
Peripheral vasodiilation
Muscular cramps
Rarely
Hypersensitivity responses (angioedema edema, urticaria, bronchospasm, hypotension and collapse)
Paradoxical bronchospasm
Increased activity
Heart rhythm violation, cardiac arrhythmia, including flickering arrhythmia, atrial fibrillation, sugarynavricular tachycardia and extrasystolia, myocardial ischemia
Lactoacidosis
Drowsiness, fatigue, chest pain
As in the case of other types of inhalation treatment, paradoxical bronchospasm can occur with the immediate amplification of a whistling breathing after the use of the drug. Such a state should be eliminated using a rapid effect inhalation broutine from another pharmacological group. The use of the drug Salbutamol, 100 μg / dose must be immediately discontinued, an alternative treatment is appointed.
Hypersensitivity to any of the drug components
Children's age up to 2 years old when using inhaler without spacer
Salbutamol is not recommended to take together with other sympathomometric broutine in the form of inhalation. If you need to use adrenergic drugs, care should be taken to avoid violation of cardiac activity.
Salbutamol cannot be taken together with non-selective beta-adrenobloclars (including eye-eye dosage forms of beta adrenoblockers). Parallel use of cardiolective beta-blockers does not reduce the Salbutamola effect. Simultaneous treatment with xanthine derivatives, diuretics and glucocorticosteroids can contribute to the development of serious hypokalemia. Also, together with Salbutotol, general anesthetics, tricyclic antidepressants and maprotilin, ergotamine and Mao inhibitors are impossible. In the case of the simultaneous use of salbutamola and heart glycosides, the risk of arrhythmia caused by hypokalemia due to the use of beta-agonists increases.
Patients should be prevented about the need to stop the use of salbutamola at least 6 hours before anesthesia using halogenated anesthetic agents.
The drug should be used through fixed time intervals in accordance with the recommendations of the doctor. In case you have missed a dose, you need to apply the drug immediately as soon as you remember this, but never take two doses at once.
The frequent use of salbutamola can lead to an increase in bronchospasm, a sudden death, and therefore, between the receptions of the next doses of the drug, it is necessary to take breaks in several hours (6 hours) the reduction of these intervals can only take place in exceptional cases. When applying a dosage aerosol, a clear execution of the following instructions is necessary: \u200b\u200bShaking a spray with an aerosol before each use, clear synchronization of inhalation and drug receipt, the most deep, intense and sufficiently long breath, breathing delay after inhalation on 10 s. Patients, including young children who are difficult to correctly perform a breathing maneuver, it is recommended to use a special adaptation (spacer), increasing the breathing volume and smoothing inaccuracies asynchronous inhalation.
The treatment of asthma should usually follow the step program at which permanent clinical control is needed using the test of the function of the respiratory system.
Bronchodulators should not be the only or basic method of treating patients with asthma light persistent, moderate, severe and unstable. Heavy asthma requires constant medical control, since such patients are a great risk of severe asthmatic crisis or even death. In such cases, the attending physician should consider the possibility of appointing the maximum recommended dose or glucocorticoids in the form of inhalation or inside.
Increasing the need to use bronchodulators of short-term action in the form of inhalation to relieve symptoms, indicates the weakening of control over the asthmatic disease. The patient must be warned that in case the bright-acting bright actors lose their effectiveness or requires more inhalations than usual, he should immediately report this to the doctor. In such cases, it is necessary to overestimate the treatment and consider the possibility of appointing anti-inflammatory therapy (for example, glucocorticoids in the form of inhalations or a course of glucocorticoids inside).
A sudden and progressive deterioration of an asthmatic disease can threaten the patient's life, in this case it is necessary to consider the possibility of using corticosteroids. For patients, risk groups need to carry out daily control of the maximum volume of lungs.
In the event that the previously used dose of salbutamola in the form of inhalation will not be able to stop symptoms, at least for 3 hours, the patient is recommended to consult a doctor to make a decision on the use of additional measures.
To increase the effectiveness of the patient's therapy, it is necessary to use the proper use of the inhaler and at the beginning of treatment to apply an inhaler under the supervision of medical personnel.
Caution is prescribed salbutamol patients with thyrotoxicosis, heart failure, hypertension, aneurysm, violation of glucose tolerance, diabetes mellitus, feuhromocytoma, myocardial ischemia, tachycardia and hypertrophic obstructive cardiomyopathy and with cordial glycosides,
Patients with cardiovascular diseases, including history, for example, ischemic heart disease, arrhythmia or severe heart failure, when prescribing salbutamol, should be warned relative to the compulsory appeal to the doctor in case of pain in the chest or other symptoms of cordial exacerbation vascular disease. It is necessary to carefully evaluate the appearance of such symptoms as shortness of breath and pain in the chest, since they can be a consequence of both cardiovascular and bronchopal functional disorders.
The use of beta-2-adrenoreceptor agonists can cause potentially dangerous hypokalemia. Special caution should be observed in severe attacks of asthma, since this effect can be enhanced by the joint use of xanthine derivatives, steroids, diuretics and hypoxia. In such situations, it is recommended to regularly monitor serum potassium concentration levels.
Salbutamol and non-selective beta-adrenoblays should not be used together (pharmacological antagonism).
Salbutamol contains a component that can give a positive result when doping control.
Application by elderly patients
Dose adjustments are not required.
Children: The use of the drug should be under the supervision of an adult.
Pregnancy and lactation period
In some studies, polydacticity in children were revealed against mothers during the pregnancy of salbutamol (the unambiguous causal connection of its occurrence with the reception of the drug was not established). In experimental studies, the presence of a teratogenic effect at Salbutamola was found: in mice with n / k administration (dose, at 11.5-115 times higher than the maximum recommended person for inhalation administration) was noted the development of wolf pastes; In rabbits during oral administration (dose, 2315 times higher than the maximum for inhalation administration) - the unexpection of the bones of the skull. Adnergic bronchodulators can be used during pregnancy, since the potential risk of placental hypoxemia for the fetus against the background of uncontrolled bronchial asthma significantly exceeds the risk associated with their use. However, when they are used during pregnancy, caution should be taken, since adrenergic bronchodulators can cause tachycardia and hyperglycemia in the mother (especially in the presence of diabetes mellitus) and the fetus, and also cause a delay in the delay of generic activities, reduced blood pressure, lung swells. Applying salbutamol during pregnancy is recommended only in case of extreme necessity and when the expected benefits exceeds the potential risk to the fetus.
If it is necessary to use the drug during breastfeeding period, it is recommended to abandon breastfeeding.
Features of the influence of the medicinal product on the ability to control the vehicle or potentially hazardous mechanisms
It should be refracted from driving and working with the mechanisms of those patients, in which, especially at high doses, there are specific adverse reactions, especially at the beginning of treatment or with joint use with alcohol. When managing motor transport and working with mechanisms, caution should be taken due to the possibility of adverse reactions to Salbutamol, such as muscle cramps and tremor
Symptoms: more frequent - hypokalemia, reduction of blood pressure, excitation, tachycardia, muscle tremor, nausea, vomiting; less frequent - hyperglycemia, respiratory alkalosis, hypoxemia, headache; Rare - hallucinations, cramps, tachyarhythmias, ventricular fluttering, expansion of peripheral vessels.
Treatment: Under the overdose of salbutamol, the best antidotees are cardiolective beta-adrenoblays. However, β-adrenoreceptor blockers must be used with caution due to the danger of bronchospasm. The use of large doses of salbutamola can cause hypocalemia, so when suspected overdose, the level of potassium in serum should be monitored and the deficiency of potassium oral preparations, with the exception of patients with severe hypokalemia, in which case intravenous administration of potassium preparations may be required.
The inhalation aerosol, dosage, 100 μg / dose, 200 doses are placed in an aluminum cylinder, equipped with a dosing valve, spray nozzle and a protective cap.
This article allows you to familiarize yourself with the instructions for the use of the drug. Salbutamol.. Reviews of site visitors - consumers of this medicine, as well as opinions of specialist doctors on the use of Salbutamola in their practice. A big request to more actively add your reviews about the preparation: helped or did not help the medicine to get rid of the disease, which complications were observed and side effects, possibly not stated by the manufacturer in annotations. Analogs of Salbutamola in the presence of available structural analogues. Use for the treatment of bronchial asthma and the relief of bronchospasm in adults, children, as well as during pregnancy and breastfeeding. Composition of the drug.
Salbutamol. - It is a selective antagonist of beta2-adrenoreceptors. In the therapeutic doses, it acts on the beta2-adrenoreceptors of the smooth muscles of the bronchi, providing a pronounced bronchhalytic effect, warns and stops bronchospasm, increases the life capacity of the lungs. Prevents the isolation of histamine, a slowly reacting substance from the fat cells and the factors of chemotaxis neutrophils. It causes a slight positive chrono and inotropic effect, expanding the coronary artery practically does not reduce blood pressure. Tocolytic action has: lowers the tone and the contractile activity of the myometrium.
It has a number of metabolic effects: reduces the potassium content in plasma, affects glycogenolysis and insulin allocation, has hyperglycemic (especially in patients with bronchial asthma) and a lipolytic effect, increases the risk of acidosis.
The effect of the drug begins 5 minutes after inhalation administration and continues for 4-6 hours.
Structure
Salbutamola sulfate + excipients.
Pharmacokinetics
After inhalation administration from 10 to 20%, the dose enters the respiratory tract. The rest of the part is delayed in the instrument or settles in the rotoglotka and then swallows. Part of the dose that remains in the respiratory tract is absorbed by the tissues of the lungs, without exposing the metabolism in the lungs, and enters the bloodstream. When entering the systemic blood flow, it can be metabolized in the liver and is excreted mainly with urine unchanged or in the form of phenolic sulfate. The degree of binding of salbutamola with plasma proteins is 10%. Part of the dose entered into the gastrointestinal tract is absorbed and subjected to intense metabolism during the "first passage" through the liver, turning into phenolic sulfate. The unchanged drug and conjugate are predominantly with urine. Most of the dose of salbutamola administered intravenously, inward or inhaled, is excreted within 72 hours.
Indications
Forms of release
Aerosol for inhalations dosed 100 μg (sometimes erroneously called spray).
Tablets 2 mg and 4 mg.
Instructions for use and dosage
Adults and children over 12 years old: 100-200 μg (1-2 inhalation doses) to relieve attacks of choking. For control over the stream of easy severity - 1-2 doses 1-4 times a day and the average severity of the disease - in the same dosage in combination with other anti-asthma drugs. For the prevention of asthma of physical effort - 20-30 minutes before the load of 1-2 doses on reception.
The daily dose should not exceed 800 μg (8 inhalation).
Instructions for using inhaler
Check the operation of the inhaler before its first use, and also if you did not use it for a while.
If more than one dose of the medicine is required, wait approximately a minute and then repeat the steps, starting with the step 2. Near the cap on the inhaler.
When performing steps 3 and 4 do not rush. At the time of release, the dose of medicine is important to do inhale as slower. At the beginning, practice around the mirror. If you notice the steam coming out from the tip of the spray or from the angles of the mouth, then start from step 2 again.
Inhaler cleaning
Inhaler should be cleaned at least once a week. Remove the metal cylinder from the plastic case and alter the case and cap with warm water. Do not use hot water. Thoroughly dry, but do not use heating devices for this. Place the cylinder back into the case and put on the cap. Do not dip the metal cylinder into the water.
Side effect
Contraindications
Application in pregnancy and breastfeeding
Contraindicated in pregnancy.
During the lactation period, it is assigned only in cases where the expected benefit for the mother exceeds any possible risk for the child.
Application in children
Children from 2 to 12 years old: with the development of the attack of bronchial asthma, as well as to prevent the bronchial asthma attacks associated with the effects of allergen or the physical activity caused, the recommended dose is 100-200 μg (1 or 2 inhalation).
special instructions
In patients with severe or unstable bronchial asthma, the use of bronchodulators should not be the main or only method of therapy. If the action of a conventional dose Salamol Eco becomes less efficient or less long (the effect of the drug should be maintained at least 3 hours), the patient should consult a doctor.
Frequent use of salbutamola can lead to an increase in bronchospasm, sudden death, and therefore between the receptions of the next doses of the drug, it is necessary to take breaks in several hours.
Improving the need for the use of inhalation agonists of beta2-adrenoreceptors with a short duration of action to control the symptoms of bronchial asthma indicates the exacerbation of the disease. In such cases, the patient's treatment plan should be revised and to resolve the issue of appointing or increasing the dose of inhalation or systemic glucocorticosteroids (GKS).
Therapy by agonists of beta2-adrenoreceptors can lead to hypokalemia. It is recommended that it is recommended for particular caution in the treatment of severe bouts of bronchial asthma, since in these cases hypocalemia may increase as a result of the simultaneous use of xanthine derivatives, GKS, diuretics, as well as due to hypoxia. In such situations it is necessary to control the level of potassium in serum.
Cylinder with salbutolo cannot pour, disassemble or throw into the fire, even if it is empty. Like most other means for inhalations in aerosol packages, salbutamol can be less effective at low temperatures. When cooling the cylinder, it is recommended to get it from a plastic case and warm your hands for a few minutes.
To determine the reversibility of bronchial patency and evaluating the effectiveness of the therapy, samples with bronchoranty drugs (bronchodlatators) are used, such as salbutamol.
The drug contains ethanol (alcohol). This fact must be taken into account when driving a vehicle.
Medicinal interaction
Theophylline and other xanthines with simultaneous use with salbutomol increase the likelihood of tachyarithmiums; Means for inhalation anesthesia, levodopa - heavy ventricular arrhythmias.
Mao inhibitors and tricyclic antidepressants enhance the action of salbutamola and can lead to a sharp decrease in blood pressure.
Salbutamol enhances the effect of CNS stimulants, side effect of thyroid hormones, heart glycosides.
Reduces the effectiveness of hypotensive drugs, nitrates.
Hypocalemia can be intensified as a result of the simultaneous use of xanthine derivatives, GKS, diuretics.
Simultaneous purpose with anticholinergic agents (including inhalation) can contribute to an increase in intraocular pressure.
Analogs of the Medication Preparation Salbutamol
Structural analogues for the acting substance:
In the absence of analogues of drugs on the active substance, you can follow the links below on the disease, which helps the appropriate drug, and see the analogues on therapeutic effects.
Content
In 1967, English scientists have developed a Salbutamol - a chemical compound capable of influencing the smooth muscles of the respiratory tract, uterus, affect the level of potassium in the blood. The broncholitic, created on its basis, belongs to the group of selective agonists of β2-adrenoreceptors - substances capable of influencing the adrenaline receptors sensitive to hormone. Today, salbutamol is the main means of therapy of the diseases of the respiratory tract.
The drug was created on the basis of salbutamol sulfate - easily dissolved water of white crystalline powder without odor. Dosage forms of broncholics Many - tablets of ordinary and prolonged action, syrup, aerosol, powder for inhalation, solution for inhalation, injection. Aerosol cylinders have a dosing valve and spray when pressed 1 dose (0.1 mg) drugs. The drug does not contain chlorofluorocarbon phones, its auxiliary substances are ethanol, hydrophorelkan, hydrofluorocarbon. The quantitative composition of different forms is given below:
Therapeutic doses of broncholics, stimulating β2-adrenoreceptors, have anti-inflammatory, musolitic (promotable sputum), bronchhalytic (relaxing bronchi muscles) effects. The use of salbutamola warns and stops bronchial spasms, including allergic and due to exercise, stimulates the production of mucus in the respiratory tract, enhances the respiratory function of the lungs.
The broncholytic agent has a tocolic effect - lowers the tone, reduces the contractile activity of the mineometry (muscle layer of the uterus), is used to prevent premature genera. It has a metabolic effect - it helps to reduce the concentration of potassium in the blood, the cleavage of glycogen to glucose, insulin secretion, blocking histamine factors, glycogenolysis (glycogen cleavage to glucose). Therapeutic doses do not have β1-adrenergic influence on the heart, pecked chemotaxis (activity) of bone marrow cells.
Any form of a substance is quickly absorbed by blood, metabolized by the liver, intestine. The circulation time of the substance along with blood can reach 9 hours. Removal of bronchospasm is faster at an inhalation method of administration. Increase the effect of broncholics can be introduced 2 doses, a further increase in the amount in the state of bronchial patency is not reflected, but contributes to the occurrence of side effects.
Prolonged tablets due to the gradual receipt of the active substance through the shell support the necessary therapeutic concentration in the plasma for 12-14 hours. After receiving non-prolonged dosage forms, the maximum effect is observed after 30 minutes, the action lasts when receiving:
Many hormonal drugs are effective in the treatment of chronic diseases of the respiratory tract, which belongs to the bronchial asthma. They are analogues of natural steroid hormones produced by adrenal glands - cortisone and cortisol. The need for their purpose occurs when a launched progressive form of the disease.
Inhalers with hormones gradually slow down the development of the inflammatory process, reduce the frequency and severity of exacerbations. Salbutamol, at bronchitis, eliminates the already happening the attack of shortness of breath, relaxing the muscles of the bronchi stimulation of their receptors. The drug is a means of rapid, but short-term removal of spasm, refers to the discharge of bronchoditics, and not hormonal medicines.
The drug is used for diseases of the respiratory tract, accompanied by the spastic states of the bronchi, as the tocologists in gynecology and the means of normalizing the level of potassium in the blood. It effectively eliminates the symptoms arising or prevents their appearance, including in contact with provoking factors, with the following states:
The size of the prescribed dose depends on the age of the patient, the nature of the disease, the dosage form of the bronchology. The amount of active substance in tablets, solution for injection, syrup, aerosol is different, so the change of dosage form is possible only in coordination with the doctor. Salbutamol children 6-12 years old are shown in the amount of half a dose for an adult, the kids are 2-6 years old the amount of medication is selected individually. Optimal is the use of bronchophile on demand when attacking bronchospasm.
Orally, the drug is taken to expand the bronchi in connection with the ineffectiveness of inhalation forms and in the threat of premature genera. Adults and children from 12 years are prescribed 1 tablet with an active substance content of 2 mg (with sharp forms of the disease - 4 mg) 3-4 times a day. Children 6-12 years old are shown a dose of 2 mg 3-4 times, 2-6 years - 1 mg 3 times a day. A special shell of a tablet of prolonged action with an 8 mg of an active substance is capable of gradually released it, providing the necessary concentration of it in the plasma for 12-14 hours.
As a tocolic agent for suppressing premature bages, 1 tablet is prescribed every 2-3 hours during the first day, then for 2 days - 1 tablet every 4 hours, then a few days before the complete cessation of the contractile activity of the uterine 1 tablet every 6 hours. With multiple pregnancy, the reception of the drug inside as the means of preventive tocolic therapy is ineffective.
Salbutamol for inhalations in the form of powder is introduced using an individual portable disk inhaler - cyclohaler. If you need to stop the bouts of bronchial asthma, 1-2 doses of 200-400 μg are prescribed once, for the prevention of exacerbation - 1-2 doses 3-4 times a day depending on the intended degree of influence of the provocating factor. The maximum daily dose (800-1000 μg), if necessary, can be increased to 1200-1600 μg.
The most convenient and frequently used form of the drug is an inhalation aerosol used by inhalation through the rotoglot. Before first use, the balloon should be shaken and perform one trial spraying into the air. For up to 4 years, inhalation is made through the intermediate tank - the spacer. An adult person requires 1-2 injection into the oral cavity, children are only one.
If the body's reactions 10 minutes after reception will not follow, it is allowed to be made 1 more injection, after which no longer use the medicine for 4-6 hours. The amount of doses during the day should be no more than 8. For the prevention of bronchospasm, 1-2 inhalations are used 15-30 minutes to physical exertion or the effects of allergen. With a weak perception of medication and exacerbation of the disease, the doctor can increase the dose.
The use of β2-adrenoreceptor drugs with healthy people leads to the expansion of the bronchi and, as a result, an increase in physical stability, therefore, in professional sports, the use of a bronchological agent may be regarded as doping use. During treatment, alcohol use should be avoided. Both with long-term treatment with the drug, and with a sudden cancellation, the risk of complications arises.
The need for the use of broncholics should not be more than 4 times a day. An increase in the frequency of use may be a consequence of the aggravation of the disease, in this case it is recommended to revise approaches to its treatment. The frequent use of the bronchology can lead to an increase in bronchospasm and even a sudden death, so there is a break between the receptions up to 6 hours. The reduction in the reception interval is possible with exceptional situations and should be reasonable.
None of the tocologists were created specifically for preventing premature birth, so all drugs affecting the contractile activity of the uterus have polyorgans (characterized by a violation of work 2 and more child organism systems) side effects. When they are used, there is a transplacental transfer of active substances.
Among other cocologists β2 agonists are relatively safe for the child, but they also penetrate the placenta and can cause tachycardia of the fetus, provoke hyperinsulamia (elevated insulin level), hypoglycemia (low glucose level). Apply a broncholic during pregnancy follows after evaluating the intended benefits and possible risks.
When appointing broncholics, it should be taken into account its influence on the pharmacology of other drugs used in order to therapy of concomitant diseases. Simultaneous with other medicines, the use of salbutamola causes the following effects:
Allergic reactions in the form of urticaria, angioedema edema, paradoxical bronchospasm against the background of the use of salbutamola are rarely fixed. When prescribing the drug during pregnancy, it should be remembered that unwanted effects can be observed simultaneously with the mother and fetus. Often the bronchology causes:
Symptoms of poisoning salbutol are tachycardia (up to 200 strikes per minute), arrhythmia, fatigue, dry mouth, dizziness. In case of overdose, blood pressure is reduced or increased, excitability, insomnia, hallucinations, muscle cramps, tremor, acidosis (violation of acid-alkaline balance with an excess acid), hypoxemia (reduced blood oxygen). In the presence of hypoxia (oxygen starvation), hypoglycemia is replaced by hyperglycemia. With signs of poisoning, symptomatic treatment is carried out.
Take the drug with increased sensitivity to its components should not be. He is contraindicated as a bronchology during pregnancy and lactation, children under 2 years old in the form of tablets, up to 4 years old - powder for inhalations. As a tocoliticism, it is impossible to use the drug in infections of generic pathways, defects and the death of the fetus, premature detachment of placenta, toxicosis, abortion threat. Contraindications to the appointment of medicines are:
Salbutamol is included in the list of medicines, the storage of which is recommended in iron cabinets and safes with the inscription "potent". Store the drug should be away from fire and high temperature sources, at home - at a temperature mode not higher than 30 ° C, in a place inaccessible to children. Freeze and store a medicine under direct sunny rays is impossible - this helps to reduce its effectiveness. Pharmacies Broncholitik is released by recipe.
There are bronchopholics that have a similar pharmacological action, created on the basis of both salbutamola phosphate and alternative actors. Some Salbutamola Analogs are presented below:
In pharmacies of the Moscow region, the drug and its synonyms are widely represented in the form of an aerosol for inhalation of domestic and foreign manufacturers. The cost of Broncholitics fluctuates depending on the form of release, the country of production and surcharges of suppliers. When ordering medicines in Internet pharmacies, the cost of delivery should be taken into account.
Name |
price, rub. |
Where can one buy |
Salbutamol-Native, Russia, inhalation solution in ampoules, №10 |
||
Salbutamol Tave, Israel, inhalation aerosol, 200 doses |
Pharmacy "Ozerski", St ..Bratyaslavskaya, 12 |
|
Salbutamol, Russia, inhalation aerosol, 90 doses |
Pharmacy "Zhivika", ul.Mitinskaya, 36 |
|
Salbutamol, Ireland, inhalation aerosol, 300 doses |
Pharmacy "Eurofarm", ul.Butirskaya, 86b |